Influence of radiotherapy technique on incidental dose to the whole ventricular system in focal irradiation of nongerminomatous germcell tumours

References

• Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the Central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820.
   PubMed Web of Science ®Google Scholar
• Fujimaki T. Central nervous system germ cell tumors: classification, clinical features, and treatment with a historical overview. J Child Neurol. 2009;24(11):1439–1445.
   PubMed Web of Science ®Google Scholar
• Murray M, Bartels U, Nishikawa R, et al. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol. 2015;16:470–477.
   Web of Science ®Google Scholar
• Frappaz D, Dhall G, Murray MJ, et al. EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. Neuro Oncol. 2022;24(4):516–527.
   PubMed Web of Science ®Google Scholar
• Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997;86(3):446–455.
   PubMed Web of Science ®Google Scholar
• Phi JH, Wang KC, Kim SK. Intracranial germ cell tumor in the molecular era. J Korean Neurosurg Soc. 2018;61(3):333–342.
   PubMed Web of Science ®Google Scholar
• Kanamori M, Kumabe T, Tominaga T. Is histological diagnosis necessary to start treatment for germ cell tumours in the pineal region? J Clin Neurosci. 2008;15(9):978–987.
   PubMed Web of Science ®Google Scholar
• Venkatasai J, Balakrishnan R, Rajkrishna B, et al. A pragmatic diagnostic approach to primary intracranial germ cell tumors and their treatment outcomes. CNS Oncol. 2021;10:CNS79.
   PubMedGoogle Scholar
• Bowzyk Al-Naeeb A, Murray M, Horan G, et al. Current management of intracranial germ cell tumours. Clin Oncol. 2018;30(4):204–214.
   Web of Science ®Google Scholar
• Park J, Park Y, Lee SU, et al. Differential dosimetric benefit of proton beam therapy over intensity modulated radiotherapy for a variety of targets in patients with intracranial germ cell tumors. Radiat Oncol. 2015;10:135.
   PubMed Web of Science ®Google Scholar
• MacDonald SM, Trofimov A, Safai S, et al. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys. 2011;79(1):121–129.
   PubMed Web of Science ®Google Scholar
• Mokhtech M, Rotondo RL, Bradley JA, et al. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Pediatr Blood Cancer. 2018;65(6):e26997.
   PubMed Web of Science ®Google Scholar
• Greenfield BJ, Jaramillo S, Abboud M, et al. Outcomes for pediatric patients with Central nervous system germ cell tumors treated with proton therapy. Clin Transl Radiat Oncol. 2016;1:9–14.
   PubMedGoogle Scholar
• Correia D, Terribilini D, Zepter S, et al. Whole-ventricular irradiation for intracranial germ cell tumors: dosimetric comparison of pencil beam scanned protons, intensity-modulated radiotherapy and volumetric-modulated arc therapy. Clin Transl Radiat Oncol. 2019;15:53–61.
   PubMed Web of Science ®Google Scholar
• Rogers S, Mosleh-Shirazi M, Saran F. Radiotherapy of localised intracranial germinoma: time to sever historical ties? Lancet Oncol. 2005;6(7):509–519.
   PubMed Web of Science ®Google Scholar
• Lee JW, Lim DH, Sung KW, et al. Induction chemotherapy reduces radiation therapy dose and volume in the treatment of intracranial germinoma: results of the SMC-G13 tri-al. Int J Radiat Oncol Biol Phys. 2020;108(3):649–656.
   PubMed Web of Science ®Google Scholar
• Yen SH, Chen YW, Huang PI, et al. Optimal treatment for intracranial germinoma: can we lower radiation dose without chemotherapy? Int J Radiat Oncol Biol Phys. 2010;77(4):980–987.
   PubMed Web of Science ®Google Scholar
• Cho J, Choi JU, Kim DS, et al. Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol. 2009;91(1):75–79.
   PubMed Web of Science ®Google Scholar
• Foote M, Millar BA, Sahgal A, et al. Clinical outcomes of adult patients with primary intracranial germinomas treated with low-dose craniospinal radiotherapy and local boost. J Neurooncol. 2010;100(3):459–463.
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Ikeda J, et al. Induction chemotherapy followed by low-dose involved-field radiotherapy for intracranial germ cell tumors. J Clin Oncol. 2002;20(3):857–865.
   PubMed Web of Science ®Google Scholar
• Calaminus G, Frappaz D, Kortmann RD, et al. Outcome of patients with intracranial non-germinomatous germ cell tumors – lessons from the SIOP-CNS-GCT-96 trial. Neuro Oncol. 2017;19(12):1661–1672.
   PubMed Web of Science ®Google Scholar
• Clinical trials.gov. Available online: https://clinicaltrials.gov/ct2/show/NCT01424839. (accessed on 22.06.2022)
   Google Scholar
• Murphy ES, Dhall G, Fangusaro J, et al. A phase 2 trial of response-based radiation therapy for localized central nervous system germ cell tumors: patterns of failure and radiation dosimetry for nongerminomatous germ cell tumors. Int J Radiat Oncol Biol Phys. 2022;113(1):143–151.
   PubMed Web of Science ®Google Scholar
• Fonseca A, Faure-Conter C, Murray MJ, et al. Pattern of treatment failures in central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): a pooled analysis of clinical trials. Neuro Oncol. 2022;24(11):1950–1961.
   PubMed Web of Science ®Google Scholar
• ACNS1123_Atlas. Available online: https://www.qarc.org/cog/ACNS1123_Atlas.pdf. (accessed on 22.06.2022)
   Google Scholar
• Alapetite C, Brisse H, Patte C, et al. Pattern of relapse and outcome of nonmetastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro Oncol. 2010;12:1318–1325.
   PubMed Web of Science ®Google Scholar
• Calaminus G, Kortmann R, Worch J, et al. SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol. 2013;15(6):788–796.
   PubMed Web of Science ®Google Scholar
• Eom KY, Kim IH, Park C, et al. Upfront chemotherapy and involved-field radiotherapy results in more relapses than extended radiotherapy for intracranial germinomas: modification in radiotherapy volume might be needed. Int J Radiat Oncol Biol Phys. 2008;71(3):667–671.
   PubMed Web of Science ®Google Scholar
• Eekers D, Di Perri D, Roelofs E, et al. Update of the EPTN atlas for CT- and MRI-based contouring in neuro-oncology. Radiother Oncol. 2021;160:259–265.
   PubMed Web of Science ®Google Scholar
• Breen WG, Blanchard MJ, Rao AN, et al. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy. Pediatr Blood Cancer. 2017;64(11):e26637.
   Web of Science ®Google Scholar
• Fangusaro J, Wu S, MacDonald S, et al. Phase II trial of response-based radiation therapy for patients with localized CNS nongerminomatous germ cell tumors: a children’s oncology group study. J Clin Oncol. 2019;37(34):3283–3290.
   PubMedGoogle Scholar